OPM Biosciences Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Public

  • Employees
  • 367

Employees

  • Stock Symbol
  • 688293

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $9.73
  • (As of Friday Closing)

OPM Biosciences General Information

Description

Shanghai OPM Biosciences Co Ltd is a biotechnology company specializing in providing cell culture solutions and comprehensive CDMO services.

Contact Information

Website
www.opmbiosciences.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Building 28, Lane 908
  • Ziping Road, Pudong New Area
  • Shanghai, 201321
  • China
+86 400
Primary Industry
Biotechnology
Stock Exchange
SHG
Vertical(s)
TMT, Life Sciences
Corporate Office
  • Building 28, Lane 908
  • Ziping Road, Pudong New Area
  • Shanghai, 201321
  • China
+86 400

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OPM Biosciences Stock Performance

As of 13-Nov-2026, OPM Biosciences’s stock price is $9.73. Its current market cap is $1.39B with 142M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$9.73 $10.32 $5.04 - $13.21 $1.39B 142M 5.71M $0.04

OPM Biosciences Financials Summary

As of 30-Sep-2026, OPM Biosciences has a trailing 12-month revenue of $119M.

In Thousands,
USD 		TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,549,713 653,584 408,154 696,256
Revenue 119,276 49,353 41,425 34,364
EBITDA 4,135 11,893 9,484 11,093
Net Income 5,968 5,798 2,934 7,638
Total Assets 570,195 321,097 313,181 324,753
Total Debt 46,813 8,147 8,951 9,789
Public Fundamental Data provided by Morningstar, Inc. disclaimer

OPM Biosciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore OPM Biosciences‘s full profile, request access.

Request a free trial

OPM Biosciences Patents

  • 6

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 3

    Pending

  • Expiring in next 12 mo

OPM Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026077485-A1 Application of dfna5/gsdme inhibitor in preparing drug for treating alzheimer's disease Pending 09-Oct-2024
WO-2026025571-A1 Expression vector for rspo1 protein and use thereof Pending 29-Jul-2024
WO-2026020536-A1 Bax gene-knockout 293f cell line and use thereof Pending 22-Jul-2024
WO-2025011385-A1 Probe for measuring capping rate of mrna sample, and kit and use method therefor Inactive 12-Jul-2023
WO-2024221577-A1 Method for serum-free adherent culture and domestication of mdck cells Inactive 26-Apr-2023 C12N5/0686
To view OPM Biosciences’s complete patent history, request access »

OPM Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OPM Biosciences Investments & Acquisitions (3)

OPM Biosciences’s most recent deal was a Merger/Acquisition with PharmaLegacy. The deal was made on 23-Jan-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
PharmaLegacy 23-Jan-2026 Merger/Acquisition BPO/Outsource Services
Haixing Biotechnology 12-Jun-2024 Corporate Biotechnology
Dima Biology 26-Jan-2022 Early Stage VC Biotechnology
To view OPM Biosciences’s complete investments and acquisitions history, request access »

OPM Biosciences ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view OPM Biosciences’s complete esg history, request access »

OPM Biosciences Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
PharmaLegacy Shanghai, China 2008

OPM Biosciences FAQs

  • When was OPM Biosciences founded?

    OPM Biosciences was founded in 2013.

  • Where is OPM Biosciences headquartered?

    OPM Biosciences is headquartered in Shanghai, China.

  • What is the size of OPM Biosciences?

    OPM Biosciences has 367 total employees.

  • What industry is OPM Biosciences in?

    OPM Biosciences’s primary industry is Biotechnology.

  • Is OPM Biosciences a private or public company?

    OPM Biosciences is a Public company.

  • What is OPM Biosciences’s stock symbol?

    The ticker symbol for OPM Biosciences is 688293.

  • What is the current stock price of OPM Biosciences?

    As of 13-Nov-2026 the stock price of OPM Biosciences is $9.73.

  • What is the current market cap of OPM Biosciences?

    The current market capitalization of OPM Biosciences is $1.39B.

  • What is OPM Biosciences’s current revenue?

    The trailing twelve month revenue for OPM Biosciences is $119M.

  • What is OPM Biosciences’s annual earnings per share (EPS)?

    OPM Biosciences’s EPS for 12 months was $0.04.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process